Showing results (761-770 of 792) with videos related to
Sort By:
Pageof 80
The Lancet. Haematology|July 30, 2023
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 studyAaron T Gerds, Srdan Verstovsek, Alessandro M Vannucchi, et al.Nucleic Acids Research|November 13, 2023
The European Nucleotide Archive in 2023David Yuan, Alisha Ahamed, Josephine Burgin, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 15, 2015
Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 TrialNandita Khera, Navneet S Majhail, Ruta Brazauskas, et al.Journal for Immunotherapy of Cancer|March 29, 2020
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization ProjectDiana M Merino, Lisa M McShane, David Fabrizio, et al.Nature|December 8, 2016
A 17-gene stemness score for rapid determination of risk in acute leukaemiaStanley W K Ng, Amanda Mitchell, James A Kennedy, et al.Blood|April 10, 2008
Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remissionDavid I Marks, Waleska S Pérez, Wensheng He, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2013
Providing personalized prognostic information for adult leukemia survivorsStephanie J Lee, Barry Storer, Hailin Wang, et al.Nature Communications|September 8, 2022
Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosisDerek W Brown, Weiyin Zhou, Youjin Wang, et al.Leukemia|February 2, 2026
JAK2V617F reprograms Hypoxia Inducible Factor-1 to induce a non-canonical hypoxia regulon in myeloproliferative neoplasmsDavid Kealy, Ruth Ellerington, Suraj Bansal, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 23, 2016
Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic RegionsRajat Kumar, Fumihiko Kimura, Kwang Woo Ahn, et al.Pageof 80